Clinton Stewart

Author PubWeight™ 14.81^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase I study of combination topotecan and carboplatin in pediatric solid tumors.	J Clin Oncol	2002	1.47
2	Topotecan combination chemotherapy in two new rodent models of retinoblastoma.	Clin Cancer Res	2005	1.37
3	A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.	Cancer Chemother Pharmacol	2010	1.27
4	Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.	Cancer Res	2011	1.21
5	In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene.	J Clin Invest	2009	1.17
6	Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).	Cancer	2005	1.12
7	Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma.	Cancer	2010	1.11
8	A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.	Pediatr Blood Cancer	2010	1.04
9	Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.	Clin Cancer Res	2012	0.97
10	Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.	Cancer	2006	0.97
11	Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program.	Pediatr Blood Cancer	2009	0.95
12	Expression of the multi-drug resistance proteins and the pregnane X receptor in treated and untreated retinoblastoma.	Curr Eye Res	2009	0.82
13	Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.	Clin Cancer Res	2002	0.80
14	A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.	Pediatr Blood Cancer	2012	0.76
15	Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients.	J Oncol Manag	2005	0.75